Real-World Comparative Effectiveness, Safety, and Health Care Costs of Oral Anticoagulants in Nonvalvular Atrial Fibrillation Patients in the U.S. Department of Defense Population

BACKGROUND: The ARISTOTLE trial demonstrated that apixaban had significantly lower rates of stroke/systemic embolism (SE) and major bleeding than warfarin; however, no direct clinical trials between apixaban and other direct oral anticoagulants (DOACs) are available. Few real-world studies comparing...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Kiran, Trocio, Jeffrey, Keshishian, Allison, Zhang, Qisu, Dina, Oluwaseyi, Mardekian, Jack, Rosenblatt, Lisa, Liu, Xianchen, Hede, Shalini, Nadkarni, Anagha, Shank, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398049/
https://www.ncbi.nlm.nih.gov/pubmed/30212268
http://dx.doi.org/10.18553/jmcp.2018.17488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398049/
https://www.ncbi.nlm.nih.gov/pubmed/30212268
http://dx.doi.org/10.18553/jmcp.2018.17488

Ejemplares similares